These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9244043)

  • 21. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial.
    Yücel N; Lefering R; Maegele M; Max M; Rossaint R; Koch A; Schwarz R; Korenkov M; Beuth J; Bach A; Schierholz J; Pulverer G; Neugebauer EA
    J Antimicrob Chemother; 2004 Dec; 54(6):1109-15. PubMed ID: 15537696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing central venous catheter-related bloodstream infections in children with cancer.
    Horvath B; Norville R; Lee D; Hyde A; Gregurich M; Hockenberry M
    Oncol Nurs Forum; 2009 Mar; 36(2):232-8. PubMed ID: 19273413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central venous catheters and infection. Routine placement of central venous catheters should be retained.
    Cooke RP; Watson NA; Myerson K; Umsankar RS; Cook J
    BMJ; 1998 Sep; 317(7159):683. PubMed ID: 9758505
    [No Abstract]   [Full Text] [Related]  

  • 24. Antimicrobial-impregnated central venous catheters.
    Paterson DL
    N Engl J Med; 1999 Jun; 340(22):1761; author reply 1762. PubMed ID: 10357631
    [No Abstract]   [Full Text] [Related]  

  • 25. Needleless connectors.
    Health Devices; 2008 Sep; 37(9):261-83. PubMed ID: 19010043
    [No Abstract]   [Full Text] [Related]  

  • 26. Maintenance of peripheral and central intravenous infusion devices by 0.9% sodium chloride with or without heparin as a potential source of catheter microbial contamination.
    Calop J; Bosson JL; Croizé J; Laurent PE
    J Hosp Infect; 2000 Oct; 46(2):161-2. PubMed ID: 11049714
    [No Abstract]   [Full Text] [Related]  

  • 27. Central venous catheters and infection. Surveillance is effective in reducing catheter related sepsis.
    Curran ET; Booth M; Hood J
    BMJ; 1998 Sep; 317(7159):683. PubMed ID: 9728013
    [No Abstract]   [Full Text] [Related]  

  • 28. Antimicrobial coating of central venous catheters: show me the data.
    Anaissie E
    Crit Care Med; 2007 Apr; 35(4):1197-9. PubMed ID: 17413788
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study.
    León C; Alvarez-Lerma F; Ruiz-Santana S; González V; de la Torre MV; Sierra R; León M; Rodrigo JJ
    Crit Care Med; 2003 May; 31(5):1318-24. PubMed ID: 12771597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Best-practice protocols: preventing central line infection.
    Earsing KA; Hobson DB; White KM
    Nurs Manage; 2005 Oct; 36(10):18-24. PubMed ID: 16210947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Habit and the hub.
    Lacroix J; Gauvin F
    Crit Care Med; 2003 May; 31(5):1583-4. PubMed ID: 12771640
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of infectious complications of central venous catheters in children].
    Uher M; Pisarcíková M; Kurák M; Cernáková A; Topolský I
    Klin Mikrobiol Infekc Lek; 2004 Oct; 10(5):214-7. PubMed ID: 15558449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of ethanol locks to prevent recurrent central line sepsis.
    Metcalf SC; Chambers ST; Pithie AD
    J Infect; 2004 Jul; 49(1):20-2. PubMed ID: 15194244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
    Betjes MG; van Agteren M
    Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Central venous catheter: epidemiology, diagnosis, prevention and treatment of infectious complications].
    Quinet B
    Arch Pediatr; 2006 Jun; 13(6):718-20. PubMed ID: 16697607
    [No Abstract]   [Full Text] [Related]  

  • 36. [Management of parenteral nutrition and central and peripheral venous catheters].
    Copelli P
    Assist Inferm Ric; 2001; 20(3):149-55. PubMed ID: 11769201
    [No Abstract]   [Full Text] [Related]  

  • 37. What information should lead to a suspicion of catheter sepsis in HPN?
    Clare A; Teubner A; Shaffer JL
    Clin Nutr; 2008 Aug; 27(4):552-6. PubMed ID: 18662842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uncertainties and future research topics in the management of suspected catheter-related infection.
    Rijnders BJ; Van Wijngaerden E; Vandecasteele SJ; Peetermans WE
    Clin Infect Dis; 2001 Dec; 33(11):1946; author reply 1949-51. PubMed ID: 11692308
    [No Abstract]   [Full Text] [Related]  

  • 39. Vascular access device choices for home care patients.
    Steinheiser MM
    Caring; 1995 May; 14(5):14-5. PubMed ID: 10142347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Implantable catheter systems].
    Willnow U
    Praxis (Bern 1994); 1998 Sep; 87(36):1135-9. PubMed ID: 9782741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.